![Ying Jun Zhang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ying Jun Zhang
Voorzitter bij Sunshine Lake Pharma Co. Ltd.
Profiel
Ying Jun Zhang is currently the Chairman at Sunshine Lake Pharma Co. Ltd.
since 2021.
Prior to this, Zhang worked as a Director at Guangdong HEC Technology Holding Co., Ltd.
Actieve functies van Ying Jun Zhang
Bedrijven | Functie | Begin |
---|---|---|
Sunshine Lake Pharma Co. Ltd.
![]() Sunshine Lake Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Shenzhen HEC Industrial Development Co., Ltd., Sunshine Lake Pharma Co. Ltd. is a Chinese company that manufactures and supplies pharmaceutical ingredients and drugs. The company is based in GD. Wen Jia Li has been the CEO of the company since 2021. Sunshine Lake Pharma Co. was acquired by Shenzhen HEC Industrial Development Co., Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. on December 23, 2022 for $330.99 million. | Voorzitter | 22-01-2021 |
Eerdere bekende functies van Ying Jun Zhang
Bedrijven | Functie | Einde |
---|---|---|
GUANGDONG HEC TECHNOLOGY HOLDING CO., LTD | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GUANGDONG HEC TECHNOLOGY HOLDING CO., LTD | Non-Energy Minerals |
Bedrijven in privébezit | 1 |
---|---|
Sunshine Lake Pharma Co. Ltd.
![]() Sunshine Lake Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Shenzhen HEC Industrial Development Co., Ltd., Sunshine Lake Pharma Co. Ltd. is a Chinese company that manufactures and supplies pharmaceutical ingredients and drugs. The company is based in GD. Wen Jia Li has been the CEO of the company since 2021. Sunshine Lake Pharma Co. was acquired by Shenzhen HEC Industrial Development Co., Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. on December 23, 2022 for $330.99 million. | Health Technology |